Progesterone and its metabolites: the potent inhibitors of the transporting activity of P-glycoprotein in the adrenal gland

Misako Ichikawa-Haraguchi, Tomoyuki Sumizawa, Akihiko Yoshimura, Tatsuhiko Furukawa, Shigeru Hiramoto, Masanori Sugita, Shin ichi Akiyama

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

P-glycroprotein (P-gp) is a transmembrane glycoprotein responsible for the multidrug resistant (MDR) phenotype in various cancer cells. It has been shown that P-gp transports various kinds of anti-cancer agents as well as hydrophobic chemicals. Although P-gp is also expressed in normal human tissues, such as liver, kidney, and adrenal gland, its function and transporting substrates in these tissues are still unknown. In previous work, we demonstrated that some compounds in human plasma modulate the transporting activity of P-gp. We also found that P-gp is expressed at a high level in the bovine adrenal gland and that this tissue contains large amount of compounds which inhibit the transporting activity of P-gp. We purified such compounds from the adrenal gland by monitoring the ability to enhance the accumulation of [3H]vincristine in MDR cells. Two majo compounds were purified and identified as progesterone and pregnenolone by nuclear magnetic resonance (NMR) analysis. Progesterone was the most potent and abundant compound that inhibited the transporting activity of P-gp among the compounds extracted from bovine adrenal gland with methanol. We also found that six authentic progesterone metabolites in the 5β-metabolic pathway but none in 5α-metabolic pathway were able to enhance the accumulation of [3H]vincristine in MDR cells and to inhibit [3H]azidopien photolabeling of P-gp in the adrenal gland. These results indicate that some progesterone metabolites can interact with P-gp and that stereoisomerism around carbon 5 of the progesterone metabolites is important for them to recognized by P-gp.

Original languageEnglish
Pages (from-to)201-208
Number of pages8
JournalBBA - General Subjects
Volume1158
Issue number3
DOIs
Publication statusPublished - 1993 Nov 28
Externally publishedYes

Fingerprint

P-Glycoprotein
Adrenal Glands
Metabolites
Progesterone
Vincristine
Tissue
Metabolic Networks and Pathways
Plasma (human)
Pregnenolone
Stereoisomerism
Liver
Methanol
Neoplasms
Glycoproteins
Magnetic Resonance Spectroscopy
Carbon
Cells
Nuclear magnetic resonance
Phenotype
Kidney

Keywords

  • (Adrenal gland)
  • Glycoprotein
  • Multidrug resistance
  • P-glycorprotein
  • Progesterone
  • Progesterone metabolite
  • Transport activity

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Progesterone and its metabolites : the potent inhibitors of the transporting activity of P-glycoprotein in the adrenal gland. / Ichikawa-Haraguchi, Misako; Sumizawa, Tomoyuki; Yoshimura, Akihiko; Furukawa, Tatsuhiko; Hiramoto, Shigeru; Sugita, Masanori; Akiyama, Shin ichi.

In: BBA - General Subjects, Vol. 1158, No. 3, 28.11.1993, p. 201-208.

Research output: Contribution to journalArticle

Ichikawa-Haraguchi, Misako ; Sumizawa, Tomoyuki ; Yoshimura, Akihiko ; Furukawa, Tatsuhiko ; Hiramoto, Shigeru ; Sugita, Masanori ; Akiyama, Shin ichi. / Progesterone and its metabolites : the potent inhibitors of the transporting activity of P-glycoprotein in the adrenal gland. In: BBA - General Subjects. 1993 ; Vol. 1158, No. 3. pp. 201-208.
@article{2dde60e84b3d4ceba7bd6ae8c2838abb,
title = "Progesterone and its metabolites: the potent inhibitors of the transporting activity of P-glycoprotein in the adrenal gland",
abstract = "P-glycroprotein (P-gp) is a transmembrane glycoprotein responsible for the multidrug resistant (MDR) phenotype in various cancer cells. It has been shown that P-gp transports various kinds of anti-cancer agents as well as hydrophobic chemicals. Although P-gp is also expressed in normal human tissues, such as liver, kidney, and adrenal gland, its function and transporting substrates in these tissues are still unknown. In previous work, we demonstrated that some compounds in human plasma modulate the transporting activity of P-gp. We also found that P-gp is expressed at a high level in the bovine adrenal gland and that this tissue contains large amount of compounds which inhibit the transporting activity of P-gp. We purified such compounds from the adrenal gland by monitoring the ability to enhance the accumulation of [3H]vincristine in MDR cells. Two majo compounds were purified and identified as progesterone and pregnenolone by nuclear magnetic resonance (NMR) analysis. Progesterone was the most potent and abundant compound that inhibited the transporting activity of P-gp among the compounds extracted from bovine adrenal gland with methanol. We also found that six authentic progesterone metabolites in the 5β-metabolic pathway but none in 5α-metabolic pathway were able to enhance the accumulation of [3H]vincristine in MDR cells and to inhibit [3H]azidopien photolabeling of P-gp in the adrenal gland. These results indicate that some progesterone metabolites can interact with P-gp and that stereoisomerism around carbon 5 of the progesterone metabolites is important for them to recognized by P-gp.",
keywords = "(Adrenal gland), Glycoprotein, Multidrug resistance, P-glycorprotein, Progesterone, Progesterone metabolite, Transport activity",
author = "Misako Ichikawa-Haraguchi and Tomoyuki Sumizawa and Akihiko Yoshimura and Tatsuhiko Furukawa and Shigeru Hiramoto and Masanori Sugita and Akiyama, {Shin ichi}",
year = "1993",
month = "11",
day = "28",
doi = "10.1016/0304-4165(93)90016-2",
language = "English",
volume = "1158",
pages = "201--208",
journal = "Biochimica et Biophysica Acta - General Subjects",
issn = "0006-3002",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Progesterone and its metabolites

T2 - the potent inhibitors of the transporting activity of P-glycoprotein in the adrenal gland

AU - Ichikawa-Haraguchi, Misako

AU - Sumizawa, Tomoyuki

AU - Yoshimura, Akihiko

AU - Furukawa, Tatsuhiko

AU - Hiramoto, Shigeru

AU - Sugita, Masanori

AU - Akiyama, Shin ichi

PY - 1993/11/28

Y1 - 1993/11/28

N2 - P-glycroprotein (P-gp) is a transmembrane glycoprotein responsible for the multidrug resistant (MDR) phenotype in various cancer cells. It has been shown that P-gp transports various kinds of anti-cancer agents as well as hydrophobic chemicals. Although P-gp is also expressed in normal human tissues, such as liver, kidney, and adrenal gland, its function and transporting substrates in these tissues are still unknown. In previous work, we demonstrated that some compounds in human plasma modulate the transporting activity of P-gp. We also found that P-gp is expressed at a high level in the bovine adrenal gland and that this tissue contains large amount of compounds which inhibit the transporting activity of P-gp. We purified such compounds from the adrenal gland by monitoring the ability to enhance the accumulation of [3H]vincristine in MDR cells. Two majo compounds were purified and identified as progesterone and pregnenolone by nuclear magnetic resonance (NMR) analysis. Progesterone was the most potent and abundant compound that inhibited the transporting activity of P-gp among the compounds extracted from bovine adrenal gland with methanol. We also found that six authentic progesterone metabolites in the 5β-metabolic pathway but none in 5α-metabolic pathway were able to enhance the accumulation of [3H]vincristine in MDR cells and to inhibit [3H]azidopien photolabeling of P-gp in the adrenal gland. These results indicate that some progesterone metabolites can interact with P-gp and that stereoisomerism around carbon 5 of the progesterone metabolites is important for them to recognized by P-gp.

AB - P-glycroprotein (P-gp) is a transmembrane glycoprotein responsible for the multidrug resistant (MDR) phenotype in various cancer cells. It has been shown that P-gp transports various kinds of anti-cancer agents as well as hydrophobic chemicals. Although P-gp is also expressed in normal human tissues, such as liver, kidney, and adrenal gland, its function and transporting substrates in these tissues are still unknown. In previous work, we demonstrated that some compounds in human plasma modulate the transporting activity of P-gp. We also found that P-gp is expressed at a high level in the bovine adrenal gland and that this tissue contains large amount of compounds which inhibit the transporting activity of P-gp. We purified such compounds from the adrenal gland by monitoring the ability to enhance the accumulation of [3H]vincristine in MDR cells. Two majo compounds were purified and identified as progesterone and pregnenolone by nuclear magnetic resonance (NMR) analysis. Progesterone was the most potent and abundant compound that inhibited the transporting activity of P-gp among the compounds extracted from bovine adrenal gland with methanol. We also found that six authentic progesterone metabolites in the 5β-metabolic pathway but none in 5α-metabolic pathway were able to enhance the accumulation of [3H]vincristine in MDR cells and to inhibit [3H]azidopien photolabeling of P-gp in the adrenal gland. These results indicate that some progesterone metabolites can interact with P-gp and that stereoisomerism around carbon 5 of the progesterone metabolites is important for them to recognized by P-gp.

KW - (Adrenal gland)

KW - Glycoprotein

KW - Multidrug resistance

KW - P-glycorprotein

KW - Progesterone

KW - Progesterone metabolite

KW - Transport activity

UR - http://www.scopus.com/inward/record.url?scp=0027440392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027440392&partnerID=8YFLogxK

U2 - 10.1016/0304-4165(93)90016-2

DO - 10.1016/0304-4165(93)90016-2

M3 - Article

C2 - 7902738

AN - SCOPUS:0027440392

VL - 1158

SP - 201

EP - 208

JO - Biochimica et Biophysica Acta - General Subjects

JF - Biochimica et Biophysica Acta - General Subjects

SN - 0006-3002

IS - 3

ER -